Using Biomonitoring Equivalents to interpret human biomonitoring data in a public health risk context
暂无分享,去创建一个
[1] R. Lauwerys,et al. Industrial chemical exposure : guidelines for biological monitoring , 1993 .
[2] Sean M Hays,et al. Biomonitoring Equivalents (BE) dossier for cadmium (Cd) (CAS No. 7440-43-9). , 2008, Regulatory toxicology and pharmacology : RTP.
[3] Gunnar F. Nordberg,et al. Routes of Exposure, Dose, and Metabolism of Metals , 2007 .
[4] M E Andersen,et al. Tissue dosimetry, pharmacokinetic modeling, and interspecies scaling factors. , 1995, Risk analysis : an official publication of the Society for Risk Analysis.
[5] R Tardif,et al. Physiologically-based pharmacokinetic modeling of a mixture of toluene and xylene in humans. , 1995, Risk analysis : an official publication of the Society for Risk Analysis.
[6] V Fiserova-Bergerova. Application of toxicokinetic models to establish biological exposure indicators. , 1990, The Annals of occupational hygiene.
[7] K Krishnan,et al. Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: a case study with toluene. , 2006, Toxicology and applied pharmacology.
[8] M. Kujawa. Environmental Health Criteria 1. Mercury. 131 Seiten, 7 Abb., 6 Tab. World Health Organization, Geneva 1976, Preis: 14,- sfrs. , 1978 .
[9] Panos G Georgopoulos,et al. Reconstructing population exposures to environmental chemicals from biomarkers: Challenges and opportunities , 2009, Journal of Exposure Science and Environmental Epidemiology.
[10] T. Fennell,et al. Metabolism and hemoglobin adduct formation of acrylamide in humans. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[11] J. van Asperen,et al. Application of physiologically based toxicokinetic modelling to study the impact of the exposure scenario on the toxicokinetics and the behavioural effects of toluene in rats. , 2003, Toxicology letters.
[12] Dana B Barr,et al. Estimating pesticide dose from urinary pesticide concentration data by creatinine correction in the Third National Health and Nutrition Examination Survey (NHANES-III) , 2004, Journal of Exposure Analysis and Environmental Epidemiology.
[13] D. Haggerty,et al. What do we mean by a , 2001 .
[14] Adam Gross,et al. Urinary cadmium as indicator of renal cadmium in humans: an autopsy study , 1998, Human & experimental toxicology.
[15] B. E. Watt,et al. Mechanisms of Toxicity, Clinical Features, and Management of Acute Chlorophenoxy Herbicide Poisoning: A Review , 2000, Journal of toxicology. Clinical toxicology.
[16] R Tardif,et al. Physiologically based modeling of the toxicokinetic interaction between toluene and m-xylene in the rat. , 1993, Toxicology and applied pharmacology.
[17] L. Costa,et al. Formation of hemoglobin adducts of acrylamide and its epoxide metabolite glycidamide in the rat. , 1991, Toxicology and applied pharmacology.
[18] J. Dorne,et al. The refinement of uncertainty/safety factors in risk assessment by the incorporation of data on toxicokinetic variability in humans. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[19] M. Churchwell,et al. DNA adducts derived from administration of acrylamide and glycidamide to mice and rats. , 2005, Mutation research.
[20] Vera Fiserova-Bergerova. Development of Biological Exposure Indices (BEIs) and their Implementation , 1987 .
[21] H. Clewell,et al. Acrylamide: Review of Toxicity Data and Dose-Response Analyses for Cancer and Noncancer Effects , 2006, Critical reviews in toxicology.
[22] Arun Sharma,et al. Evaluation of certain food additives and contaminants. , 2000, World Health Organization technical report series.
[23] Harvey J Clewell,et al. Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling , 2007, Journal of Exposure Science and Environmental Epidemiology.
[24] David J. Williams,et al. Cadmium Levels in the Lung, Liver, Kidney Cortex, and Urine Samples from Australians without Occupational Exposure to Metals , 2002, Archives of environmental health.
[25] James M. Hassett,et al. URINARY CADMIUM ELIMINATION AS A BIOMARKER OF EXPOSURE FOR EVALUATING A CADMIUM DIETARY EXPOSURE - BIOKINETICS MODEL , 2001, Journal of toxicology and environmental health. Part A.
[26] Charles Timchalk,et al. Comparative inter-species pharmacokinetics of phenoxyacetic acid herbicides and related organic acids. evidence that the dog is not a relevant species for evaluation of human health risk. , 2004, Toxicology.
[27] Hugh A Barton,et al. The Acquisition and Application of Absorption, Distribution, Metabolism, and Excretion (ADME) Data in Agricultural Chemical Safety Assessments , 2006, Critical reviews in toxicology.
[28] Melvin E. Andersen,et al. What do we Mean by Dose , 1995 .
[29] L L Needham,et al. Exposure assessment: serum levels of TCDD in Seveso, Italy. , 1999, Environmental research.
[30] G. Nordberg,et al. A kinetic model of cadmium metabolism in the human being. , 1978, Environmental research.
[31] G. Blau,et al. The fate of 2,4-dichlorophenoxyacetic acid (2,4-D) following oral administration to man. , 1977, Toxicology.
[32] Rodney Snyder,et al. Role of CYP2E1 in the epoxidation of acrylamide to glycidamide and formation of DNA and hemoglobin adducts. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[33] L Edler,et al. Risk assessment of substances that are both genotoxic and carcinogenic report of an International Conference organized by EFSA and WHO with support of ILSI Europe. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[34] Conrad Brunk,et al. Guidelines for the communication of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop. , 2008, Regulatory toxicology and pharmacology : RTP.
[35] R A Becker,et al. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective. , 2007, Regulatory toxicology and pharmacology : RTP.
[36] Sean M Hays,et al. Biomonitoring Equivalents (BE) dossier for 2,4-dichlorophenoxyacetic acid (2,4-D) (CAS No. 94-75-7). , 2008, Regulatory toxicology and pharmacology : RTP.
[37] Conrad Brunk,et al. Guidelines for the derivation of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop. , 2008, Regulatory toxicology and pharmacology : RTP.
[38] R. Lauwerys,et al. Industrial Chemical Exposure: Guidelines for Biological Monitoring, Third Edition , 1983 .
[39] Lutz Edler,et al. Risk assessment of substances that are both genotoxic and carcinogenic: Report of an International Conference organized by EFSA and WHO with support of ILSI Europe , 2006 .
[40] B. N. Gupta,et al. Absorption and excretion of 2,4-dichlorophenoxyacetic acid in man. , 1974, Xenobiotica; the fate of foreign compounds in biological systems.
[41] B. van Ravenzwaay,et al. Comparative metabolism of 2,4-dichlorophenoxyacetic acid (2,4-D) in rat and dog , 2003, Xenobiotica; the fate of foreign compounds in biological systems.
[42] Canada.,et al. Canadian Environmental Protection Act and commentary , 2005 .
[43] John F. Young,et al. Relationships between biomarkers of exposure and toxicokinetics in Fischer 344 rats and B6C3F1 mice administered single doses of acrylamide and glycidamide and multiple doses of acrylamide. , 2006, Toxicology and applied pharmacology.
[44] James S Bus,et al. Strategies to assess systemic exposure of chemicals in subchronic/chronic diet and drinking water studies. , 2006, Toxicology and applied pharmacology.
[45] Ken Sexton,et al. Human Biomonitoring of Environmental Chemicals , 2004 .
[46] G Würtzen,et al. Threshold of toxicological concern for chemical substances present in the diet: a practical tool for assessing the need for toxicity testing. , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[47] M. Okino,et al. Use of a pharmacokinetic model to assess chlorpyrifos exposure and dose in children, based on urinary biomarker measurements. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.
[48] C H Pierce,et al. Interindividual differences in 2H8-toluene toxicokinetics assessed by semiempirical physiologically based model. , 1996, Toxicology and applied pharmacology.
[49] L. Bankir,et al. Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.
[50] Hugh A. Barton,et al. Biomonitoring Equivalents (BE) dossier for toluene (CAS No. 108-88-3). , 2008, Regulatory toxicology and pharmacology : RTP.
[51] Vernon A Benignus,et al. Quantitative comparisons of the acute neurotoxicity of toluene in rats and humans. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[52] Vernon A Benignus,et al. A dosimetric analysis of the acute behavioral effects of inhaled toluene in rats. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[53] S M Hays,et al. Introduction to the Biomonitoring Equivalents Pilot Project: development of guidelines for the derivation and communication of Biomonitoring Equivalents. , 2008, Regulatory toxicology and pharmacology : RTP.
[54] Harvey J Clewell,et al. Development of a Screening Approach to Interpret Human Biomonitoring Data on Volatile Organic Compounds: Reverse Dosimetry on Biomonitoring Data for Trichloroethylene , 2007, Risk analysis : an official publication of the Society for Risk Analysis.
[55] D. Knopp,et al. Biological monitoring of 2,4-dichlorophenoxyacetic acid-exposed workers in agriculture and forestry , 1991, International archives of occupational and environmental health.
[56] Gurumurthy Ramachandran,et al. Children’s Exposure to Volatile Organic Compounds as Determined by Longitudinal Measurements in Blood , 2004, Environmental health perspectives.
[57] Sean M Hays,et al. Biomonitoring Equivalents (BE) dossier for acrylamide (AA) (CAS No. 79-06-1). , 2008, Regulatory toxicology and pharmacology : RTP.
[58] Pierre O. Droz,et al. Simulation of Toluene in Venous Blood with a Physiologically Based Pharmacokinetic Model: Its Application to Biological Exposure Index Development , 1996 .
[59] L. Ehrenberg,et al. Evaluation of genetic risks of alkylating agents. II. Haemoglobin as a dose monitor. , 1976, Mutation research.
[60] P Apostoli,et al. Biological monitoring of cadmium exposure--an Italian experience. , 1993, Scandinavian journal of work, environment & health.
[61] John F. Young,et al. Toxicokinetics of acrylamide and glycidamide in Fischer 344 rats. , 2005, Toxicology and applied pharmacology.
[62] D. Knopp,et al. Assessment of exposure to 2,4-dichlorophenoxyacetic acid in the chemical industry: results of a five year biological monitoring study. , 1994, Occupational and environmental medicine.
[63] Chlorinated Paraffins,et al. Canadian Environmental Protection Act Priority Substances List Assessment Report , 1995 .
[64] Jerry L. Campbell,et al. Quantitative interpretation of human biomonitoring data. , 2008, Toxicology and applied pharmacology.